Published in J Am Soc Nephrol on May 21, 2008
The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients. Am J Med (2013) 2.77
Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD. J Am Soc Nephrol (2014) 1.50
Comparative analysis of ferumoxytol and gadoteridol enhancement using T1- and T2-weighted MRI in neuroimaging. AJR Am J Roentgenol (2011) 1.18
Considerations and challenges in defining optimal iron utilization in hemodialysis. J Am Soc Nephrol (2014) 1.11
Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients. PLoS One (2012) 0.97
Iron sucrose impairs phagocytic function and promotes apoptosis in polymorphonuclear leukocytes. Am J Nephrol (2012) 0.91
Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD. Int Urol Nephrol (2011) 0.90
GST M1 polymorphism associates with DNA oxidative damage and mortality among hemodialysis patients. J Am Soc Nephrol (2008) 0.89
Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study. Nephrol Dial Transplant (2014) 0.86
The conundrum of serum ferritin measurement in patients with chronic kidney disease. Nat Clin Pract Nephrol (2008) 0.81
At pharmacologically relevant concentrations intravenous iron preparations cause pancreatic beta cell death. Am J Transl Res (2013) 0.81
Correction of iron deficiency in the cardiorenal syndrome. Int J Nephrol (2011) 0.76
Oxidative stress and age-related changes in T cells: is thalassemia a model of accelerated immune system aging? Cent Eur J Immunol (2016) 0.75
Improved method for the determination of blood glutathione. J Lab Clin Med (1963) 13.04
KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis (2006) 5.28
Oxidative decay of DNA. J Biol Chem (1997) 3.94
Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury. Am J Kidney Dis (2002) 2.89
Endogenous oxidative DNA damage, aging, and cancer. Free Radic Res Commun (1989) 2.79
Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study. J Am Soc Nephrol (2007) 2.62
Analysis of a form of oxidative DNA damage, 8-hydroxy-2'-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res (1997) 2.54
Time-dependent associations between iron and mortality in hemodialysis patients. J Am Soc Nephrol (2005) 2.49
Simultaneous determination of retinol and alpha-tocopherol in serum or plasma by liquid chromatography. Clin Chem (1983) 2.34
Parenteral iron nephrotoxicity: potential mechanisms and consequences. Kidney Int (2004) 1.98
Assays of oxidative DNA damage biomarkers 8-oxo-2'-deoxyguanosine and 8-oxoguanine in nuclear DNA and biological fluids by high-performance liquid chromatography with electrochemical detection. Methods Enzymol (1994) 1.62
Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation (2002) 1.58
Role of oxidative DNA damage in cancer initiation and promotion. Eur J Cancer Prev (1998) 1.56
Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients. J Am Soc Nephrol (2000) 1.50
Protective effect of vitamin C on 8-hydroxy-2'-deoxyguanosine level in peripheral blood lymphocytes of chronic hemodialysis patients. Kidney Int (2004) 1.48
Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann Rheum Dis (1993) 1.45
Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease. Kidney Int (2004) 1.35
Normalization of elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet. Cancer Res (2001) 1.30
Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients. Kidney Int (2000) 1.25
Cigarette smoking induces formation of 8-hydroxydeoxyguanosine, one of the oxidative DNA damages in human peripheral leukocytes. Free Radic Res Commun (1990) 1.24
Clinical aspects of iron use in the anemia of kidney disease. J Am Soc Nephrol (2007) 1.22
Oxidative damage to DNA constituents by iron-mediated fenton reactions. The deoxyguanosine family. J Biol Chem (1996) 1.14
Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo. Eur J Clin Invest (2002) 1.10
Isolation of DNA from blood. Anal Biochem (1991) 1.09
Oxidative DNA damage (8-hydroxydeoxyguanosine) and body iron status: a study on 2507 healthy people. Free Radic Biol Med (2003) 1.07
Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic Biol Med (1996) 1.06
Oxidative damage to DNA constituents by iron-mediated fenton reactions. The deoxycytidine family. J Biol Chem (1996) 1.06
Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy. Nephrol Dial Transplant (1999) 1.04
Targeting higher ferritin concentrations with intravenous iron dextran lowers erythropoietin requirement in hemodialysis patients. Clin Nephrol (2003) 1.03
A simple colorimetric method for ascorbic acid determination in blood plasma. Clin Chim Acta (1978) 1.03
Reduction of oxidation during the preparation of DNA and analysis of 8-hydroxy-2'-deoxyguanosine. Chem Res Toxicol (1998) 1.02
The evaluation of iron status in hemodialysis patients. J Am Soc Nephrol (1996) 1.00
Erythropoietin hyporesponsiveness: from iron deficiency to iron overload. Kidney Int Suppl (1999) 0.96
Induction of protein oxidation by intravenous iron in hemodialysis patients: role of inflammation. Am J Kidney Dis (2002) 0.94
Determination of oxidized glutathione in blood: high-performance liquid chromatography. Methods Enzymol (1994) 0.92
Carbonyl stress induced by intravenous iron during haemodialysis. Nephrol Dial Transplant (2003) 0.92
Increase in plasma esterified F2-isoprostanes following intravenous iron infusion in patients on hemodialysis. Kidney Int (2001) 0.92
Importance of iron supply for erythropoietin therapy. Nephrol Dial Transplant (1995) 0.91
Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels. Nephrol Dial Transplant (2007) 0.90
Increased oxidative damage to peripheral blood leukocyte DNA in chronic peritoneal dialysis patients. J Am Soc Nephrol (2002) 0.90
Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis. J Am Soc Nephrol (2000) 0.90
Oxidative stress in haemodialysis. QJM (1994) 0.90
8-hydroxy-2'-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients. Am J Kidney Dis (2000) 0.88
Melatonin prevents oxidative stress resulting from iron and erythropoietin administration. Am J Kidney Dis (2001) 0.87
Induction of 8-hydroxydeoxyguanosine in Ah-responsive mouse liver by iron and Aroclor 1254. Carcinogenesis (1992) 0.86
Relationship between the intracellular reactive oxygen species and the induction of oxidative DNA damage in human neutrophil-like cells. Carcinogenesis (1996) 0.84
Intradialytic granulocyte reactive oxygen species production: a prospective, crossover trial. J Am Soc Nephrol (1993) 0.83
Free oxygen species metabolism during haemodialysis with different membranes. Nephrol Dial Transplant (1991) 0.82
Increased 8-hydroxyguanine levels in DNA and its repair activity in rat kidney after administration of a renal carcinogen, ferric nitrilotriacetate. Carcinogenesis (1996) 0.81
DNA damage of lymphocytes in experimental chronic renal failure: beneficial effects of losartan. Kidney Int Suppl (2001) 0.80
High iron storage levels are associated with increased DNA oxidative injury in patients on regular hemodialysis. Clin Exp Nephrol (2005) 0.77
Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med (2004) 3.19
Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. Int J Biochem Cell Biol (2005) 2.91
Oxidative stress-related alteration of the copy number of mitochondrial DNA in human leukocytes. Free Radic Res (2003) 2.70
Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells. Stem Cells (2008) 2.34
Association of postdischarge rehabilitation with mortality in intensive care unit survivors of sepsis. Am J Respir Crit Care Med (2014) 2.27
Attenuation of oxidative stress after varicocelectomy in subfertile patients with varicocele. J Urol (2007) 2.20
Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutat Res (2004) 2.01
Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer. Genes Chromosomes Cancer (2005) 1.99
Mitochondrial genome instability and mtDNA depletion in human cancers. Ann N Y Acad Sci (2005) 1.97
Prognostic variables in thoracic esophageal squamous cell carcinoma. Ann Thorac Surg (2009) 1.81
Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer. Genes Chromosomes Cancer (2006) 1.77
Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus. Ann Intern Med (2015) 1.71
Cisd2 deficiency drives premature aging and causes mitochondria-mediated defects in mice. Genes Dev (2009) 1.61
Genetic analysis in Leber's hereditary optic neuropathy using the comparative genomic hybridization technique. Clin Experiment Ophthalmol (2003) 1.45
Oxidative stress, mitochondrial DNA mutation, and apoptosis in aging. Exp Biol Med (Maywood) (2007) 1.45
Effects of intravenous iron saccharate on improving severe anemia in rheumatoid arthritis patients. Clin Rheumatol (2011) 1.42
Leber's hereditary optic neuropathy: a multifactorial disease. Prog Retin Eye Res (2006) 1.37
Mitochondria and aging. Adv Exp Med Biol (2012) 1.37
8-hydroxy-2'-deoxyguanosine in leukocyte DNA of spermatic vein as a biomarker of oxidative stress in patients with varicocele. J Urol (2004) 1.34
Oxidative stress response elicited by mitochondrial dysfunction: implication in the pathophysiology of aging. Exp Biol Med (Maywood) (2013) 1.30
Mitochondrial DNA instability and metabolic shift in human cancers. Int J Mol Sci (2009) 1.29
Low copy number and low oxidative damage of mitochondrial DNA are associated with tumor progression in lung cancer tissues after neoadjuvant chemotherapy. Interact Cardiovasc Thorac Surg (2008) 1.28
Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis. Drug Metab Dispos (2005) 1.21
Differentiation of apoptosis from necrosis by dynamic changes of reduced nicotinamide adenine dinucleotide fluorescence lifetime in live cells. J Biomed Opt (2008) 1.19
AMPK-mediated increase of glycolysis as an adaptive response to oxidative stress in human cells: implication of the cell survival in mitochondrial diseases. Biochim Biophys Acta (2011) 1.18
Increase in mitochondrial mass in human fibroblasts under oxidative stress and during replicative cell senescence. J Biomed Sci (2002) 1.18
Oxidative stress-induced depolymerization of microtubules and alteration of mitochondrial mass in human cells. Ann N Y Acad Sci (2005) 1.10
Molecular Mechanisms of UV-Induced Apoptosis and Its Effects on Skin Residential Cells: The Implication in UV-Based Phototherapy. Int J Mol Sci (2013) 1.09
Association of the Y402H polymorphism in complement factor H gene and neovascular age-related macular degeneration in Chinese patients. Invest Ophthalmol Vis Sci (2006) 1.09
Multiplex amplified product-length polymorphism analysis of 36 mitochondrial single-nucleotide polymorphisms for haplogrouping of East Asian populations. Electrophoresis (2005) 1.06
The role of mitochondrial DNA alterations in esophageal squamous cell carcinomas. J Thorac Cardiovasc Surg (2009) 1.05
The emerging role of SOX2 in cell proliferation and survival and its crosstalk with oncogenic signaling in lung cancer. Stem Cells (2013) 1.05
Hemorrhagic acalculous cholecystitis: an unusual location of uremic bleeding. J Chin Med Assoc (2009) 1.04
Mitochondrial bioenergetic function and metabolic plasticity in stem cell differentiation and cellular reprogramming. Biochim Biophys Acta (2011) 1.02
Increase of oxidative stress in human sperm with lower motility. Fertil Steril (2007) 1.02
Association of mitochondrial deoxyribonucleic acid 16189 variant (T->C transition) with metabolic syndrome in Chinese adults. J Clin Endocrinol Metab (2005) 1.02
Mitochondria-mediated caspase-independent apoptosis induced by cadmium in normal human lung cells. J Cell Biochem (2003) 1.01
Hypercalcemia in a renal transplant recipient suffering with Pneumocystis carinii pneumonia. Am J Kidney Dis (2002) 1.01
More impact of microalbuminuria on retinopathy than moderately reduced GFR among type 2 diabetic patients. Diabetes Care (2012) 1.00
Response to the increase of oxidative stress and mutation of mitochondrial DNA in aging. Biochim Biophys Acta (2009) 1.00
Mediating of caspase-independent apoptosis by cadmium through the mitochondria-ROS pathway in MRC-5 fibroblasts. J Cell Biochem (2004) 1.00
Oxidative-stress-related changes in the livers of bile-duct-ligated rats. J Biomed Sci (2003) 1.00
Peripheral blood mitochondrial DNA content and dysregulation of glucose metabolism. Diabetes Res Clin Pract (2008) 0.99
A lady with a broken haemodialysis catheter fragment. Nephrol Dial Transplant (2002) 0.98
A persistent level of Cisd2 extends healthy lifespan and delays aging in mice. Hum Mol Genet (2012) 0.97
Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma. Cell Cycle (2015) 0.97
Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients. PLoS One (2012) 0.97
Mitochondrial dysfunction in insulin insensitivity: implication of mitochondrial role in type 2 diabetes. Ann N Y Acad Sci (2010) 0.96
Regulation of mitochondrial F(o)F(1)ATPase activity by Sirt3-catalyzed deacetylation and its deficiency in human cells harboring 4977bp deletion of mitochondrial DNA. Biochim Biophys Acta (2012) 0.96
Induced pluripotent stem cells without c-Myc attenuate acute kidney injury via downregulating the signaling of oxidative stress and inflammation in ischemia-reperfusion rats. Cell Transplant (2012) 0.96
Reduced nicotinamide adenine dinucleotide fluorescence lifetime separates human mesenchymal stem cells from differentiated progenies. J Biomed Opt (2008) 0.96
Oral bioavailability, urinary excretion and organ distribution of melamine in Sprague-Dawley rats by high-performance liquid chromatography with tandem mass spectrometry. J Agric Food Chem (2010) 0.96
Inhibitory effects of hypoxia on metabolic switch and osteogenic differentiation of human mesenchymal stem cells. Stem Cells (2013) 0.96
Resveratrol Impedes the Stemness, Epithelial-Mesenchymal Transition, and Metabolic Reprogramming of Cancer Stem Cells in Nasopharyngeal Carcinoma through p53 Activation. Evid Based Complement Alternat Med (2013) 0.95
Somatic mutations in mitochondrial genome and their potential roles in the progression of human gastric cancer. Biochim Biophys Acta (2009) 0.95
Mitochondrial dysfunction leads to impairment of insulin sensitivity and adiponectin secretion in adipocytes. FEBS J (2013) 0.95
Increase in oxidative damage to lipids and proteins in skeletal muscle of uremic patients. Free Radic Res (2002) 0.95
Aberrant cell proliferation by enhanced mitochondrial biogenesis via mtTFA in arsenical skin cancers. Am J Pathol (2011) 0.95
Upregulation of mitochondrial function and antioxidant defense in the differentiation of stem cells. Biochim Biophys Acta (2009) 0.95
High mitochondrial DNA copy number and bioenergetic function are associated with tumor invasion of esophageal squamous cell carcinoma cell lines. Int J Mol Sci (2012) 0.94
Repeated ovarian stimulations induce oxidative damage and mitochondrial DNA mutations in mouse ovaries. Ann N Y Acad Sci (2005) 0.94
Alteration of the copy number of mitochondrial DNA in leukocytes of patients with hyperlipidemia. Ann N Y Acad Sci (2005) 0.93
Leukocyte mitochondrial DNA alteration in systemic lupus erythematosus and its relevance to the susceptibility to lupus nephritis. Int J Mol Sci (2012) 0.93
Somatic mutations of mitochondrial genome in hepatocellular carcinoma. Mitochondrion (2009) 0.93
Evaluation of cytokeratin-19 mRNA as a tumor marker in the peripheral blood of nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy. Int J Cancer (2002) 0.93
A common mitochondrial DNA variant and increased body mass index as associated factors for development of type 2 diabetes: Additive effects of genetic and environmental factors. J Clin Endocrinol Metab (2006) 0.93
Decoy receptor 3 enhances tumor progression via induction of tumor-associated macrophages. J Immunol (2012) 0.93
Mitochondrial DNA mutation-elicited oxidative stress, oxidative damage, and altered gene expression in cultured cells of patients with MERRF syndrome. Mol Neurobiol (2010) 0.92
Age-associated decrease of oxidative repair enzymes, human 8-oxoguanine DNA glycosylases (hOgg1), in human aging. J Radiat Res (2003) 0.92
Multiple rearrangements of mitochondrial DNA in unfertilized human oocytes. Fertil Steril (2002) 0.92
Clinical phenotype, prognosis and mitochondrial DNA mutation load in mitochondrial encephalomyopathies. J Biomed Sci (2002) 0.92
Cadmium-based quantum dot induced autophagy formation for cell survival via oxidative stress. Chem Res Toxicol (2013) 0.91
Sperm mitochondrial DNA depletion in men with asthenospermia. Fertil Steril (2004) 0.91
Mitochondrial respiratory dysfunction-elicited oxidative stress and posttranslational protein modification in mitochondrial diseases. Ann N Y Acad Sci (2010) 0.91
Visualizing common deletion of mitochondrial DNA-augmented mitochondrial reactive oxygen species generation and apoptosis upon oxidative stress. Biochim Biophys Acta (2005) 0.90
Urinary calculi and risk of cancer: a nationwide population-based study. Medicine (Baltimore) (2014) 0.90
Increased oxidative damage to peripheral blood leukocyte DNA in chronic peritoneal dialysis patients. J Am Soc Nephrol (2002) 0.90
Increased oxidative damage with altered antioxidative status in type 2 diabetic patients harboring the 16189 T to C variant of mitochondrial DNA. Ann N Y Acad Sci (2005) 0.90
Mitochondrial dysfunction represses HIF-1α protein synthesis through AMPK activation in human hepatoma HepG2 cells. Biochim Biophys Acta (2013) 0.89
Detection of DNA mutations associated with mitochondrial diseases by Agilent 2100 bioanalyzer. Clin Chim Acta (2002) 0.89
GST M1 polymorphism associates with DNA oxidative damage and mortality among hemodialysis patients. J Am Soc Nephrol (2008) 0.89
A prevalent POLG CAG microsatellite length allele in humans and African great apes. Mamm Genome (2004) 0.89
Mitochondrial DNA mutations and oxidative damage in skeletal muscle of patients with chronic uremia. J Biomed Sci (2002) 0.89
Mitochondrial DNA mutation and depletion increase the susceptibility of human cells to apoptosis. Ann N Y Acad Sci (2004) 0.89
Determination of the minimal melatonin exposure required to induce osteoblast differentiation from human mesenchymal stem cells and these effects on downstream signaling pathways. J Pineal Res (2010) 0.89
Polymorphisms of glutathione S-transferase M1 and male infertility in Taiwanese patients with varicocele. Hum Reprod (2002) 0.88
Effects of intravascular laser irradiation of blood in mitochondria dysfunction and oxidative stress in adults with chronic spinal cord injury. Photomed Laser Surg (2012) 0.88
High-calorie supplementation increases serum leptin levels and improves response to rHuEPO in long-term hemodialysis patients. Am J Kidney Dis (2005) 0.88
Determination of melamine in rat plasma, liver, kidney, spleen, bladder and brain by liquid chromatography-tandem mass spectrometry. J Chromatogr A (2009) 0.88
Decoy receptor 3, a novel inflammatory marker, and mortality in hemodialysis patients. Clin J Am Soc Nephrol (2012) 0.86
Serum bilirubin links UGT1A1*28 polymorphism and predicts long-term cardiovascular events and mortality in chronic hemodialysis patients. Clin J Am Soc Nephrol (2011) 0.86
Anaemia management in patients with chronic kidney disease: Taiwan practice guidelines. Nephrology (Carlton) (2014) 0.86
Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients. Nephrol Dial Transplant (2003) 0.86
Enhanced generation of mitochondrial reactive oxygen species in cybrids containing 4977-bp mitochondrial DNA deletion. Ann N Y Acad Sci (2005) 0.86
Differential expression of antioxidant enzymes in various hepatocellular carcinoma cell lines. J Cell Biochem (2005) 0.86